Modelling the cost-effectiveness of orlistat as a treatment for obesity in primary care

2020-02-25T10:08:12Z (GMT) by Roberta Ara L. Blake
OBJECTIVES Obesity represents a considerable and increasing health problem. The objective of this research was to assess the clinical and cost-effectiveness of orlistat in overweight and obese patients in primary care in the UK